Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Immunology  |  Musculoskeletal  |  Rheumatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Rheumatoid Arthritis Clinical Trials

A listing of Rheumatoid Arthritis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (414) clinical trials

This study is designed to evaluate the efficacy and safety of tofacitinib modified release formulation (11mg QD) versus tofacitinib modified release formulation plus continued methotrexate treatment in subjects with moderate to severe rheumatoid arthritis who are insufficiently responding to their stable dose of methotrexate treatment.

Phase

Winthrop University Hospital Clinical Trials Center in conjunction with The Division of Rheumatology and The Arthritis and Rheumatic Disease Center is conducting a clinical research study on an investigational medication, for patient with dry mouth associated with SjÖgren’s Syndrome. This study will evaluate the safety and effectiveness of an investigational ...

Phase N/A

A research study is evaluating an investigational medication for Rheumatoid Arthritis (RA). This research study may be an option if you: Are between 18 and 80 years of age (inclusive) Have been diagnosed with RA for at least 3 months Have received weekly methotrexate (MTX) treatment for at least 3 ...

Phase N/A

FINCH 1 is enrolling RA patients who have taken methotrexate (also known as MTX, TREXALL, or RASUVO) but have not yet tried a biologic treatment. Filgotinib (study drug) is an oral medication designed to reduce joint inflammation.

Phase

Rheumatoid Arthritis is a chronic immune/inflammatory disease characterized by persistent synovitis. If you have a diagnosis of rheumatoid arthritis, a clinical research study could be an option for you. New England Research is currently conducting a study to test the safety and effectiveness of the the drug Olokizumab in patients ...

Phase

Adults with Rheumatoid Arthritis with inadequate response to MTX may qualify to have Vectra DA guided treatment for 12 months.

Phase